Obigen Pharma Inc. (TPEX:7876)
Taiwan · Delayed Price · Currency is TWD 36.45
0.00 (0.00%)
At close: Jul 16, 2026
Obigen Pharma Market Cap
Obigen Pharma has a market cap or net worth of 3.9 billion as of July 16, 2026.
Market Cap
3.90B
Enterprise Value
3.46B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
36.45
ChartMarket Cap Chart
Since November 24, 2025, Obigen Pharma's market cap has decreased from 4.62B to 3.90B, a decrease of -15.62%. That is a compound annual growth rate of -23.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 3.90B | -6.54% |
| Dec 31, 2025 | 4.17B | -9.72% |
| Nov 24, 2025 | 4.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 31.25B |
| HanchorBio | 22.07B |
| Elixiron Immunotherapeutics (Cayman) Limited | 11.09B |
| Uwell Biopharma | 7.39B |
| Intelligene | 7.37B |
| Tripartite Therapeutics | 6.92B |
| Pet Pharm Biotech | 2.86B |
| BIONET Therapeutics | 2.18B |